The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Rosuvastatin 40 mg Film-coated Tablets



Brillpharma (Ireland) LimitedPA22749/017/004

Main Information

Trade NameRosuvastatin 40 mg Film-coated Tablets
Active SubstancesRosuvastatin
Dosage FormFilm-coated tablet
Licence HolderBrillpharma (Ireland) Limited
Licence NumberPA22749/017/004

Group Information

ATC CodeC10AA HMG CoA reductase inhibitors
C10AA07 rosuvastatin

Status

License statusAuthorised
Licence Issued28/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to the general public
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0006-004-003
Interchangeable List DocumentPDF of Interchangeable List
« Back